Firefly Neuroscience and Neurosigma Partner To Expand Non-Drug Pediatric ADHD Care

Firefly Neuroscience (NASDAQ: AIFF) partnered with NeuroSigma to expand U.S. clinician awareness of and access to the Monarch eTNS System. The collaboration links Firefly's precision-neuroscience AI capabilities with NeuroSigma's bioelectronic medical-device platform, though no financial terms or expected revenue impact were disclosed.